Archives of Osteoporosis

, 13:37 | Cite as

Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged ≥ 75 years and long-term care insurance claims data in Japan

  • Takahiro Mori
  • Nanako Tamiya
  • Xueying Jin
  • Boyoung Jeon
  • Satoru Yoshie
  • Katsuya Iijima
  • Tatsuro Ishizaki
Original Article
  • 57 Downloads

Abstract

Summary

Little is known about hip fracture expenditure in Japan. Using claims data obtained from a core city near Tokyo, we estimated the mean healthcare expenditure and monthly long-term care expenditure post-hip fracture to be ¥2,600,000 (US$29,500) and ¥113,000 (US$1290), respectively.

Purpose

We aimed to estimate healthcare and long-term care expenditures post-hip fracture in Japan.

Methods

Healthcare insurance claims data for adults aged  75 years were merged with long-term care insurance claims data. We analyzed the data of hip fracture patients who were admitted to non-diagnosis procedure combination/per-diem payment system (DPC/PDPS) hospitals in a core city near Tokyo between April 2012 and September 2013. We estimated healthcare expenditure, namely, the difference between total payments 6 months pre- and 6 months post-hip fracture, and monthly long-term care expenditure for those who did not use long-term care insurance pre-hip fracture, but who commenced long-term care insurance post-hip fracture. We also performed multiple linear regressions to examine the associations of healthcare or long-term care expenditure with various factors.

Results

The estimated mean healthcare (n = 78) and monthly long-term care (n = 42) expenditures post-hip fracture were ¥2,600,000 (US$29,500) and ¥113,000 (US$1290), respectively. In multiple linear regressions, healthcare expenditure was positively associated with longer duration of hospital stay (p = 0.036), and negatively associated with higher Charlson Comorbidity Index scores (p = 0.015). Monthly long-term care expenditure was positively associated with higher care-needs level post-hip fracture (p = 0.022), and usage of institutional care services (p < 0.001).

Conclusions

This is the first study to estimate healthcare and long-term care expenditures post-hip fracture using claims data in Japan. Further studies are needed that include healthcare claims data at both DPC/PDPS and non-DPC/PDPS hospitals to capture the lifelong course of long-term care required post-hip fracture.

Keywords

Healthcare expenditure Long-term care expenditure Hip fracture Claims data Osteoporosis 

Notes

Acknowledgements

We thank Dr. Tetsuo Tsuji for obtaining healthcare and long-term care claims data from the local city government and thank Dr. Hideto Takahashi for providing statistical support. We also thank Editage (www.editage.jp) for English language editing.

Author contributions

Takahiro Mori: conception and design, analysis and interpretation of data, drafting the article, revising the article critically for important intellectual content, final approval. Takahiro Mori had full access to all of the data in the study and took responsibility for the integrity of the data and the accuracy of the data analysis.

Nanako Tamiya: conception and design, collection of data, revising the article critically for important intellectual content, final approval.

Xueying Jin: analysis and interpretation of data, revising the article critically for important intellectual content, final approval.

Boyoung Jeon: analysis and interpretation of data, revising the article critically for important intellectual content, final approval.

Satoru Yoshie: conception and design, collection of data, revising the article critically for important intellectual content, final approval.

Katsuya Iijima: conception and design, collection of data, revising the article critically for important intellectual content, final approval.

Tatsuro Ishizaki: conception and design, collection of data, revising the article critically for important intellectual content, final approval.

Compliance with ethical standards

The ethics committee of the University of Tsukuba approved this study (Approved number: 1075).

Conflicts of interest

None.

References

  1. 1.
    Orimo H, Yaegashi Y, Hosoi T, Fukushima Y, Onoda T, Hashimoto T, Sakata K (2016) Hip fracture incidence in Japan: estimates of new patients in 2012 and 25-year trends. Osteoporos Int 27:1777–1784CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Japanese Ministry of Health, Labour and Welfare (2014) Comprehensive survey of living conditions in 2013 (Japanese). http://www.mhlw.go.jp/toukei/list/dl/20-21-h25.pdf Accessed 16 Febr 2018
  3. 3.
    Kondo A, Zierler B, Isokawa Y, Hagino H, Ito Y (2009) Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan. Health Policy 91:204–210CrossRefPubMedGoogle Scholar
  4. 4.
    Ikegami N, Yoo B, Hashimoto H, Matsumoto M, Ogata H, Babazono A, Watanabe R, Shibuya K, Yang B, Reich M (2011) Japanese universal health coverage: evolution, achievements, and challenges. Lancet 378:1106–1115CrossRefPubMedGoogle Scholar
  5. 5.
    Japanese Ministry of Health, Labour and Welfare (2015) Health and medical services (English). http://www.mhlw.go.jp/english/wp/wp-hw9/dl/02e.pdf Accessed 16 Febr 2018
  6. 6.
    Tamiya N, Noguchi H, Nishi A, Reich M, Ikegami N, Hashimoto H, Shibuya K, Kawachi I, Campbell J (2011) Population ageing and wellbeing: lessons from Japan’s long-term care insurance policy. Lancet 378:1183–1192CrossRefPubMedGoogle Scholar
  7. 7.
    Japan Ministry of Health L, and Welfare (2016) Long-term care insurance system of Japan (English). http://www.mhlw.go.jp/english/policy/care-welfare/care-welfare-elderly/dl/ltcisj_e.pdf Accessed 16 Febr 2018
  8. 8.
    Hamada H, Sekimoto M, Imanaka Y (2012) Effects of the per diem prospective payment system with DRG-like grouping system (DPC/PDPS) on resource usage and healthcare quality in Japan. Health Policy 107:194–201CrossRefPubMedGoogle Scholar
  9. 9.
    Japanese Ministry of Health, Labour and Welfare (2016) Outline of revision of medical fee reimbursement in 2016 (part related to DPC/PDPS) (Japanese). http://www.mhlw.go.jp/file/06-Seisakujouhou-12400000-Hokenkyoku/0000115023.pdf Accessed 16 Febr 2018
  10. 10.
    X-Rates. http://www.x-rates.com Accessed 16 Febr 2018
  11. 11.
    Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, Januel J-M, Sundararajan V (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173:676–682CrossRefPubMedGoogle Scholar
  12. 12.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRefPubMedGoogle Scholar
  13. 13.
    Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J, Saunders L, Beck C, Feasby T, Ghali W (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRefPubMedGoogle Scholar
  14. 14.
    Kilgore ML, Morrisey MA, Becker DJ, Gary LC, Curtis JR, Saag KG, Yun H, Matthews R, Smith W, Taylor A, Arora T, Delzell E (2009) Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005. J Bone Miner Res 24:2050–2055CrossRefPubMedGoogle Scholar
  15. 15.
    Regression with STATA chapter 2 – Regression diagnostics. UCLA Institute for Digital Research and Education https://stats.idre.ucla.edu/stata/webbooks/reg/chapter2/stata-webbooksregressionwith-statachapter-2-regression-diagnostics/ Accessed 10 Oct 2017
  16. 16.
    Ishizaki T, Imanaka Y, Oh E, Kuwabara K, Hirose M, Hayashida K, Harada Y (2004) Association of hospital resource use with comorbidity status and patient age among hip fracture patients in Japan. Health Policy 69:179–187CrossRefPubMedGoogle Scholar
  17. 17.
    Nikkel L, Fox E, Black K, Davis C, Andersen L, Hollenbeak C (2012) Impact of comorbidities on hospitalization costs following hip fracture. J Bone Joint Surg Am 94:9–17CrossRefPubMedGoogle Scholar
  18. 18.
    Aigner R, Meier FT, Eschbach D, Hack J, Bliemel C, Ruchholtz S, Bücking B (2016) Patient factors associated with increased acute care costs of hip fractures: a detailed analysis of 402 patients. Arch Osteoporos 11:38CrossRefPubMedGoogle Scholar
  19. 19.
    Kashiwagi M, Tamiya N, Sato M, Yano E (2013) Factors associated with the use of home-visit nursing services covered by the long-term care insurance in rural Japan: a cross-sectional study. BMC Geriatr 13:1CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Kilgore M, Curtis J, Delzell E, Becker D, Arora T, Saag K, Morrisey M (2013) A close examination of healthcare expenditures related to fractures. J Bone Miner Res 28:816–820CrossRefPubMedGoogle Scholar
  21. 21.
    Johnson DJ, Greenberg SE, Sathiyakumar V, Thakore R, Ehrenfeld JM, Obremskey WT, Sethi MK (2015) Relationship between the Charlson Comorbidity Index and cost of treating hip fractures: implications for bundled payment. J Orthop Traumatol 16:209–213CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Toson B, Harvey L, Close J (2015) The ICD-10 Charlson Comorbidity Index predicted mortality but not resource utilization following hip fracture. J Clin Epidemiol 68:44–51CrossRefPubMedGoogle Scholar
  23. 23.
    Sahota O, Morgan N, Moran C (2012) The direct cost of acute hip fracture care in care home residents in the UK. Osteoporos Int 23:917–920CrossRefPubMedGoogle Scholar
  24. 24.
    Lawrence T, White C, Wenn R, Moran C (2005) The current hospital costs of treating hip fractures. Injury 36:88–91CrossRefPubMedGoogle Scholar
  25. 25.
    Garcia A, Bonnaig J, Yoneda Z, Richards J, Ehrenfeld J, Obremskey W, Jahangir A, Sethi M (2012) Patient variables which may predict length of stay and hospital costs in elderly patients with hip fracture. J Orthop Trauma 26:620–623CrossRefPubMedGoogle Scholar
  26. 26.
    Olivares-Tirado P, Tamiya N, Kashiwagi M, Kashiwagi K (2011) Predictors of the highest long-term care expenditures in Japan. BMC Health Serv Res 11:103CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Japanese Ministry of Health, Labour and Welfare (2013) Demographic change in Japan’s aging society. http://www8.cao.go.jp/kourei/whitepaper/w-2013/zenbun/s1_1_1_01.html Accessed 16 Febr 2018
  28. 28.
    Mori T, Crandall C, Ganz D (2017) Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan. Osteoporos Int 28:1733–1744CrossRefPubMedGoogle Scholar
  29. 29.
    Japanese Ministry of Health, Labour and Welfare (2017) Experimental implementation of cost-effectiveness analysis into medical fee payment (Japanese). http://www.mhlw.go.jp/stf/shingi/shingi-chuo.html?tid=128159 Accessed 16 Febr 2018

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2018

Authors and Affiliations

  • Takahiro Mori
    • 1
    • 2
    • 3
  • Nanako Tamiya
    • 1
  • Xueying Jin
    • 1
  • Boyoung Jeon
    • 1
  • Satoru Yoshie
    • 4
  • Katsuya Iijima
    • 4
  • Tatsuro Ishizaki
    • 5
  1. 1.Research and Development Center for Health Services, Faculty of MedicineUniversity of TsukubaTsukubaJapan
  2. 2.Department of General Internal MedicineEastern Chiba Medical CenterToganeJapan
  3. 3.Department of General Medical Science, Graduate School of MedicineChiba UniversityChibaJapan
  4. 4.Institute of GerontologyUniversity of TokyoTokyoJapan
  5. 5.Human Care Research TeamTokyo Metropolitan Institute of GerontologyTokyoJapan

Personalised recommendations